Literature DB >> 25450687

Atypical nuclear localization of VIP receptors in glioma cell lines and patients.

Alice Barbarin1, Paule Séité1, Julie Godet2, Souheyla Bensalma1, Jean-Marc Muller1, Corinne Chadéneau3.   

Abstract

An increasing number of G protein-coupled receptors, like receptors for vasoactive intestinal peptide (VIP), are found in cell nucleus. As VIP receptors are involved in the regulation of glioma cell proliferation and migration, we investigated the expression and the nuclear localization of the VIP receptors VPAC1 and VPAC2 in this cancer. First, by applying Western blot and immunofluorescence detection in three human glioblastoma (GBM) cell lines, we observed a strong nuclear staining for the VPAC1 receptor and a weak nuclear VPAC2 receptor staining. Second, immunohistochemical staining of VPAC1 and VPAC2 on tissue microarrays (TMA) showed that the two receptors were expressed in normal brain and glioma tissues. Expression in the non-nuclear compartment of the two receptors significantly increased with the grade of the tumors. Analysis of nuclear staining revealed a significant increase of VPAC1 staining with glioma grade, with up to 50% of GBM displaying strong VPAC1 nuclear staining, whereas nuclear VPAC2 staining remained marginal. The increase in VPAC receptor expression with glioma grades and the enhanced nuclear localization of the VPAC1 receptors in GBM might be of importance for glioma progression.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  GPCR; Glioblastoma; Glioma; Nuclear localization; Tissue microarrays; VIP receptors

Mesh:

Substances:

Year:  2014        PMID: 25450687     DOI: 10.1016/j.bbrc.2014.10.113

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

Review 1.  Vasoactive intestinal peptide/pituitary adenylate cyclase activating polypeptide, and their receptors and cancer.

Authors:  Terry W Moody; Bernardo Nuche-Berenguer; Robert T Jensen
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2016-02       Impact factor: 3.243

2.  Expression and localization of VPAC1, the major receptor of vasoactive intestinal peptide along the length of the intestine.

Authors:  Dulari Jayawardena; Grace Guzman; Ravinder K Gill; Waddah A Alrefai; Hayat Onyuksel; Pradeep K Dudeja
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-04-06       Impact factor: 4.052

3.  A composite network of conserved and tissue specific gene interactions reveals possible genetic interactions in glioma.

Authors:  André Voigt; Katja Nowick; Eivind Almaas
Journal:  PLoS Comput Biol       Date:  2017-09-28       Impact factor: 4.475

4.  The palmitoylation of the N-terminal extracellular Cys37 mediates the nuclear translocation of VPAC1 contributing to its anti-apoptotic activity.

Authors:  Rongjie Yu; Hongyu Liu; Xinhe Peng; Yue Cui; Suqin Song; Like Wang; Huahua Zhang; An Hong; Tianhong Zhou
Journal:  Oncotarget       Date:  2017-06-27

5.  VPAC Receptor Subtypes Tune Purinergic Neuron-to-Glia Communication in the Murine Submucosal Plexus.

Authors:  Candice Fung; Werend Boesmans; Carla Cirillo; Jaime P P Foong; Joel C Bornstein; Pieter Vanden Berghe
Journal:  Front Cell Neurosci       Date:  2017-04-25       Impact factor: 5.505

6.  Activation of Th lymphocytes alters pattern expression and cellular location of VIP receptors in healthy donors and early arthritis patients.

Authors:  R Villanueva-Romero; I Gutiérrez-Cañas; M Carrión; I González-Álvaro; J M Rodríguez-Frade; M Mellado; C Martínez; R P Gomariz; Y Juarranz
Journal:  Sci Rep       Date:  2019-05-14       Impact factor: 4.379

Review 7.  Insights into Nuclear G-Protein-Coupled Receptors as Therapeutic Targets in Non-Communicable Diseases.

Authors:  Salomé Gonçalves-Monteiro; Rita Ribeiro-Oliveira; Maria Sofia Vieira-Rocha; Martin Vojtek; Joana B Sousa; Carmen Diniz
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-07

8.  CD44 promotes the migration of bone marrow-derived mesenchymal stem cells toward glioma.

Authors:  Qiang Yin; Yang-Yang Zhou; Peng Wang; L I Ma; Peng Li; Xiao-Guang Wang; Chun-Hua She; Wen-Liang Li
Journal:  Oncol Lett       Date:  2016-02-24       Impact factor: 2.967

Review 9.  Current status and potential challenges of mesenchymal stem cell-based therapy for malignant gliomas.

Authors:  Qing Zhang; Wei Xiang; Dong-Ye Yi; Bing-Zhou Xue; Wan-Wan Wen; Ahmed Abdelmaksoud; Nan-Xiang Xiong; Xiao-Bing Jiang; Hong-Yang Zhao; Peng Fu
Journal:  Stem Cell Res Ther       Date:  2018-08-24       Impact factor: 6.832

Review 10.  Pituitary Adenylate Cyclase-Activating Polypeptide: 30 Years in Research Spotlight and 600 Million Years in Service.

Authors:  Viktoria Denes; Peter Geck; Adrienn Mester; Robert Gabriel
Journal:  J Clin Med       Date:  2019-09-18       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.